PCR and molecular diagnostics: Biotechnologic integration in clinical laboratories.
Many clinically relevant biomarkers and molecular targets used in cancer research including EGFR, KRAS, BRAF, BCR-ABL1, circulating tumor DNA (ctDNA), and methylated SEPT9 will be examined.